Ecosystem and offering

SPEX benefits from a global healthcare ecosystem via partnerships and relationships with embassies, chambers of commerce, trade bodies, accelerators & incubators, universities, hospitals, payors and healthcare systems across all continents to source the highest caliber technologies worldwide.

SPEX specialises and invests in companies at an early stage and provides a unique offering to support them and help them succeed.

Incubating mode

Our seasoned investors, mentors, academics and industry experts assist our companies through one to one meetings and exclusive targeted events

Learn more

Deal flow

Our deal flow comes from investment programmes, incubators, accelerators, co-investors, universities, hospitals, and foreign embassies.

Learn more

Technological validation

We have access to an expert panel of reviewers to further validate the science and technology.

 

Learn more

Due diligence

We have access to an expert panel of reviewers to further validate the science and technology.

Learn more

NHS and other healthcare system access

Our team provides unparalleled access to executives and decision makers within global healthcare organisations and policy makers.

Learn more

Distribution and exits

We have access to distribution channels and potential exit strategies (i.e. global insurance companies and private health providers) and position of our already NHS vetted companies for long term distribution into the NHS and healthcare systems globally.

Learn more

Incubating mode

Our seasoned investors, mentors, academics and industry experts assist our companies through one to one meetings and exclusive targeted events.

Deal flow

Our deal flow comes from investment programmes, incubators, accelerators, co-investors, universities, hospitals, and foreign embassies.

Technological validation

We have access to an expert panel of reviewers to further validate the science and technology.

Due Diligence

We carry out a detailed and comprehensive commercial due diligence process tailor made around early stage and series A/B companies.

NHS and other healthcare system access

Our team provides unparalleled access to executives and decision makers within global healthcare organisations and policy makers.

Distribution and exits

We have access to distribution channels and potential exit strategies (i.e. global insurance companies and private health providers) and position of our already NHS vetted companies for long term distribution into the NHS and healthcare systems globally.